Evidence map›Paper›PMID 33184093›Full record

ArticleBiology open2020

Efficient and crucial quality control of HAP1 cell ploidy status.

Tobias B Beigl, Ine Kjosås, Emilie Seljeseth, Nina Glomnes, Henriette Aksnes

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Multimodal framework to resolve variants of uncertain significance inbioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9.Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tobias B BeiglDepartment of Biomedicine, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0002-8068-3643
Ine KjosåsDepartment of Biological Sciences, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0003-0619-9658
Emilie SeljesethDepartment of Biological Sciences, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0002-9526-2657
Nina GlomnesDepartment of Biomedicine, University of Bergen, 5020 Bergen, Norway.
Henriette AksnesDepartment of Biomedicine, University of Bergen, 5020 Bergen, Norway henriette.aksnes@uib.no.ORCID 0000-0003-4968-2324
University of Bergen · NOUniversity of Stuttgart · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The near-haploid human cell line HAP1 recently became a popular subject for CRISPR/Cas9 editing, since only one allele requires modification. Through the gene-editing service at Horizon Discovery, there are at present more than 7500 edited cell lines available and the number continuously increases. The haploid nature of HAP1 is unstable as cultures become diploid with time. Here, we demonstrated some fundamental differences between haploid and diploid HAP1 cells, hence underlining the need for taking control over ploidy status in HAP1 cultures prior to phenotyping. Consequently, we optimized a procedure to determine the ploidy of HAP1 by flow cytometry in order to obtain diploid cultures and avoid ploidy status as an interfering variable in experiments. Furthermore, in order to facilitate this quality control, we validated a size-based cell sorting procedure to obtain the diploid culture more rapidly. Hence, we provide here two streamlined protocols for quality controlling the ploidy of HAP1 cells and document their validity and necessity.This article has an associated First Person interview with the co-first authors of the paper.

Indexed as

PloidiesCell LineCells, CulturedCRISPR-Cas SystemsDiploidyFlow CytometryGene EditingGene Knockdown TechniquesHaploidyHumansNerve Tissue ProteinsHAP1 protein, humanNerve Tissue ProteinsCas9 enzymeCell culture quality controlCell phenotype analysesclustered palindromic repeatsCRISPR/Cas9Gene editingHAP1Microscopy genetic disease cell modelNear-haploid human cell line

Identifiers

PMID33184093
PMCPMC7673356
OpenAlexW3105834441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.